Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Danaher_Corporation
|
| gptkbp:collaboratesWith |
Research institutions
|
| gptkbp:focusesOn |
Biopharmaceuticals
|
| gptkbp:hasCompetitors |
gptkb:Boehringer_Ingelheim
gptkb:Thermo_Fisher_Scientific gptkb:Sartorius_AG AbbVie Merck KGaA |
| gptkbp:hasEmployees |
Thousands
|
| gptkbp:hasPart |
Analytical instruments
Training and support services Regulatory compliance services Quality control services Bioprocess equipment Process development services Single-use technologies Software solutions for bioprocessing |
| gptkbp:hasProductLine |
gptkb:Xcellerex
KUBio FlexFactory Sartorius_products |
| gptkbp:hasResidence |
Billions
|
| gptkbp:headquarteredIn |
gptkb:Marlborough,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
GE Biopharma
|
| gptkbp:isActiveIn |
Global markets
|
| gptkbp:isIncorporatedIn |
gptkb:United_States
|
| gptkbp:isInvolvedIn |
Supply chain management
Vaccine development Clinical trials Technology transfer Process optimization Therapeutic development Regulatory submissions Market access strategies Manufacturing support Partnerships with biotech firms Capacity expansion Innovation in bioprocessing Product commercialization |
| gptkbp:isKnownFor |
End-to-end bioprocessing solutions
Innovative bioprocessing technologies |
| gptkbp:isPartOf |
Life_Sciences_sector
|
| gptkbp:isRecognizedFor |
Quality and reliability
|
| gptkbp:offers |
Cell and gene therapy products
|
| gptkbp:partOf |
gptkb:General_Electric
|
| gptkbp:provides |
Bioprocessing solutions
|
| gptkbp:serves |
Pharmaceutical industry
Biotechnology industry |
| gptkbp:wasFoundedIn |
2019
|